John Roberts is the Medical Director at Elastagen Pty Ltd. since May 2014.
Having graduated in medicine from the Royal College of Surgeons in Ireland, John chose to specialise in Pharmaceutical Medicine after spending several years practicing hospital-based medicine in the UK and working for the flying-doctor service in Kenya.
Within the pharmaceutical industry, he has since gained significant development and business experience in a broad range of therapeutic areas including vaccination, immunotherapy, infectious disease, oncology, wound healing, aesthetics, regenerative medicine and addiction. John has first-hand experience of all phases of clinical development with a particular emphasis on practical design and fast track delivery of phase I and phase II proof-of-concept studies.
John has a strong commercial awareness having held senior management and executive board positions in both private and public pharmaceutical companies including Merieux UK (now Sanofi-Pasteur MSD), Cantab Pharmaceuticals plc, Xenova Group plc, Microscience plc and Intercytex plc. John has been responsible for numerous clinical studies in Europe, North America, Australasia, India and Vietnam.